Emami Limited (EMAMILTD.NS)
Kolkata, IN
Emami Limited is an enterprise dedicated to the development, production, and global distribution of a wide array of personal care and healthcare merchandise, serving both Indian and international markets. The company's extensive product portfolio is organized under several key brands. For instance, the Boroplus brand encompasses items like ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, vasocare herbal petroleum jelly, aloe vera gel, and various hygiene essentials. Under the Navratna label, consumers can find cool oil, extra thanda, gold ayurvedic oil, a therapeutic ayurvedic body massage and stress relief oil, as well as maxx cool talc and cool talc. The Zandu collection features diverse balms (including an ultra-power variant), quick relief roll-ons, ortho vedic oil, a broader range of healthcare products, pancharishta, nityam, kesari jivan, and ayurvedic hand sanitizers. Addressing men's specific grooming needs, the Fair and Handsome brand offers a radiance cream and an instant radiance face wash. Haircare solutions are provided through the Kesh King line, while pain alleviation is offered by Mentho Plus balm and Fast Relief ointment. Emami also markets prickly heat powder via the Dermicool brand; non-sticky hair oil under Emami 7 Oils in One; deodorants through HE; and hair colors branded as Diamond Shine. Its range further extends to talc under Emami Golden Beauty, herbal fairness cream from Emami Naturally Fair, home hygiene solutions by Emasol, and a variety of skin products (for normal, dry, and ultra-dry skin) within the Cream21 brand. The company was established in 1974 and its corporate base is situated in Kolkata, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.48% | -2.20% | -14.11% | -14.61% | -24.96% | -25.90% | -32.62% | -1.10% | -25.78% | -22.82% | +774.92% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 5 | -1 |
| Buy | 13 | -1 |
| Hold | 4 | +1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%-0.8% Q1'26: -3.9% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-3.9% Q1'26: -11.8% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+24.3% Q1'26: +23.2% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+22.7% ★ Q1'26: +18.1% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+36.9% ★ Q1'26: +27.4% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.16× ★ Q1'26: 0.19× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2010 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 20 Rev. Ana. 10 EPS Ana. |
Mar 2027 20 Rev. Ana. 13 EPS Ana. |
Mar 2028 20 Rev. Ana. 16 EPS Ana. |
Mar 2029 11 Rev. Ana. 10 EPS Ana. |
Mar 2030 11 Rev. Ana. 10 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
9.71B
est: 10.58B (-8.2%)
|
12.02B
est: 12.70B (-5.4%)
|
13.70B
est: 15.18B (-9.7%)
|
15.95B
est: 17.39B (-8.2%)
|
17.00B
est: 19.25B (-11.7%)
|
20.76B
est: 22.11B (-6.1%)
|
23.58B
est: 26.61B (-11.4%)
|
24.88B
est: 27.40B (-9.2%)
|
25.31B
est: 25.99B (-2.6%)
|
26.95B
est: 27.32B (-1.4%)
|
26.55B
est: 27.59B (-3.8%)
|
28.81B
est: 28.55B (+0.9%)
|
31.87B
est: 31.80B (+0.2%)
|
34.06B
est: 34.05B (+0.0%)
|
35.78B
est: 35.63B (+0.4%)
|
38.09B
est: 38.08B (+0.0%)
|
38.88B
38.02B – 39.38B
+2.1% YoY
|
41.83B
39.90B – 44.53B
+7.6% YoY
|
45.18B
42.44B – 47.83B
+8.0% YoY
|
48.45B
45.85B – 51.43B
+7.3% YoY
|
53.45B
50.58B – 56.74B
+10.3% YoY
|
| EBITDA |
2.46B
est: 3.11B (-20.7%)
|
2.56B
est: 2.41B (+6.2%)
|
2.98B
est: 3.52B (-15.3%)
|
3.49B
est: 3.59B (-2.8%)
|
4.34B
est: 4.78B (-9.1%)
|
5.48B
est: 6.59B (-16.8%)
|
6.99B
est: 8.38B (-16.6%)
|
7.67B
est: 6.67B (+15.0%)
|
7.30B
est: 6.64B (+9.9%)
|
7.37B
est: 7.12B (+3.6%)
|
7.02B
est: 7.40B (-5.1%)
|
8.93B
est: 6.56B (+36.1%)
|
9.61B
est: 7.27B (+32.3%)
|
8.73B
est: 7.96B (+9.7%)
|
9.65B
est: 8.65B (+11.6%)
|
10.39B
est: 10.59B (-1.9%)
|
10.69B
10.45B – 10.82B
+0.9% YoY
|
11.50B
10.97B – 12.24B
+7.6% YoY
|
12.42B
11.67B – 13.15B
+8.0% YoY
|
13.32B
12.60B – 14.14B
+7.3% YoY
|
14.69B
13.90B – 15.59B
+10.3% YoY
|
| EBIT |
2.33B
est: 2.27B (+2.4%)
|
2.40B
est: 2.62B (-8.4%)
|
2.79B
est: 2.89B (-3.5%)
|
3.27B
est: 3.15B (+4.0%)
|
3.99B
est: 3.70B (+7.9%)
|
5.14B
est: 4.67B (+9.9%)
|
4.45B
est: 6.29B (-29.2%)
|
4.58B
est: 4.44B (+3.2%)
|
4.19B
est: 4.34B (-3.5%)
|
4.15B
est: 4.33B (-4.2%)
|
3.66B
est: 4.01B (-8.5%)
|
5.26B
est: 3.39B (+55.0%)
|
6.28B
est: 3.76B (+67.0%)
|
6.43B
est: 4.12B (+56.3%)
|
7.80B
est: 4.47B (+74.3%)
|
8.61B
est: 10.50B (-18.1%)
|
10.60B
10.37B – 10.74B
+0.9% YoY
|
11.41B
10.88B – 12.14B
+7.6% YoY
|
12.32B
11.57B – 13.04B
+8.0% YoY
|
13.21B
12.50B – 14.03B
+7.3% YoY
|
14.58B
13.79B – 15.47B
+10.3% YoY
|
| Net Income |
1.70B
est: 1.67B (+1.5%)
|
2.29B
est: 2.04B (+12.3%)
|
2.59B
est: 2.73B (-5.2%)
|
3.15B
est: 2.93B (+7.6%)
|
4.02B
est: 3.57B (+12.9%)
|
4.86B
est: 4.79B (+1.4%)
|
3.64B
est: 5.89B (-38.3%)
|
3.40B
est: 3.68B (-7.5%)
|
3.07B
est: 3.24B (-5.3%)
|
3.03B
est: 3.21B (-5.5%)
|
3.03B
est: 3.06B (-1.0%)
|
4.55B
est: 2.91B (+56.4%)
|
8.39B
est: 3.22B (+160.5%)
|
6.40B
est: 3.53B (+81.4%)
|
7.24B
est: 3.83B (+88.8%)
|
8.06B
est: 8.48B (-4.9%)
|
8.58B
8.30B – 9.03B
+1.2% YoY
|
8.35B
7.93B – 8.85B
-2.7% YoY
|
9.20B
8.42B – 11.14B
+10.2% YoY
|
10.05B
9.35B – 10.85B
+9.3% YoY
|
11.79B
10.96B – 12.73B
+17.3% YoY
|
| SGA |
723.44M
est: 2.56B (-71.7%)
|
3.30B
est: 4.66B (-29.2%)
|
3.32B
est: 5.63B (-41.0%)
|
3.90B
est: 5.72B (-31.8%)
|
4.07B
est: 6.87B (-40.8%)
|
5.53B
est: 7.88B (-29.7%)
|
6.01B
est: 10.32B (-41.7%)
|
6.11B
est: 8.24B (-25.8%)
|
6.43B
est: 8.45B (-23.9%)
|
6.48B
est: 9.86B (-34.3%)
|
6.59B
est: 9.93B (-33.6%)
|
6.56B
est: 9.80B (-33.1%)
|
7.31B
est: 10.86B (-32.7%)
|
8.57B
est: 11.89B (-27.9%)
|
9.28B
est: 12.92B (-28.2%)
|
10.04B
est: 9.24B (+8.7%)
|
9.33B
9.12B – 9.45B
+0.9% YoY
|
10.04B
9.57B – 10.68B
+7.6% YoY
|
10.84B
10.18B – 11.48B
+8.0% YoY
|
11.62B
11.00B – 12.34B
+7.3% YoY
|
12.82B
12.14B – 13.61B
+10.3% YoY
|
| EPS |
3.88
est: 3.83 (+1.2%)
|
5.04
est: 5.27 (-4.4%)
|
5.66
est: 5.89 (-3.8%)
|
6.94
est: 7.15 (-2.9%)
|
8.87
est: 9.04 (-1.8%)
|
10.70
est: 10.40 (+2.9%)
|
8.01
est: 11.12 (-28.0%)
|
7.50
est: 11.84 (-36.7%)
|
6.77
est: 11.60 (-41.6%)
|
6.68
est: 11.53 (-42.1%)
|
6.67
est: 12.30 (-45.8%)
|
10.23
est: 14.06 (-27.2%)
|
18.88
est: 17.25 (+9.4%)
|
14.50
est: 16.09 (-9.9%)
|
16.55
est: 17.56 (-5.7%)
|
18.48
est: 19.79 (-6.6%)
|
19.66
19.02 – 20.68
-0.7% YoY
|
19.12
18.16 – 20.28
-2.7% YoY
|
21.07
19.28 – 25.51
+10.2% YoY
|
23.02
21.41 – 24.86
+9.3% YoY
|
27.00
25.12 – 29.16
+17.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-02 | A | 4/5 | 5/5 | 5/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-06-01 | A | 4/5 | 5/5 | 5/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 5/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Emerging Markets Ex-China ETF VEXC | 0.01% | 24.3K | 0.07% |
| 2 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.01% | 461.5K | 0.17% |
| 3 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.01% | 461.5K | 0.17% |
| 4 | Vanguard FTSE Asia ex Japan Shares Index ETF VAE.AX | 0.01% | 44.0K | 0.40% |
| 5 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.01% | 94.0K | 0.48% |
| 6 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.01% | 212.1K | 0.26% |
| 7 | Schwab Emerging Markets Equity ETF SCHE | 0.01% | 850.4K | 0.06% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.01% | 10.47M | 0.06% |
| 9 | Vanguard ESG International Stock ETF VSGX | 0.00% | 144.1K | 0.10% |
| 10 | Vanguard All-World ex-US Shares Index ETF VEU.AX | 0.00% | 85.3K | 0.04% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mohan Goenka | Vice Chairman & Whole Time Director | 86M | male |
| Harsha Vardhan Agarwal | MD & Vice Chairman | 86M | male |
| Priti A. Sureka | Whole Time Director | 48M | female |
| Sushil Kumar Goenka | Whole Time Director | 48M | male |
| Prashant Goenka | Whole Time Director | 48M | male |
| Naresh Hiralal Bhansali | Chief Executive Officer of Finance, Strategy & Business Development and Chief Financial Officer | 30M | male |
| Radhe Shyam Goenka | Founder & Non-Executive Chairman | 1M | male |
| Radhe Shyam Agarwal | Founder & Chairman Emeritus | 200.0K | male |
| Rajesh Sharma | President of Finance & Investor Relations | — | male |
| Sanjay Madan | President of Operations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EMAMILTD.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
